Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks
Top Cited Papers
- 15 August 2018
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 132 (15), 1561-1567
- https://doi.org/10.1182/blood-2017-04-737445
Abstract
Intravascular large B-cell lymphoma (IVLBCL) is a rare, clinically aggressive lymphoma entity characterized by an almost exclusive growth of large cells within the lumen of all sized blood vessels. The reasons for this peculiar localization of neoplastic cells are only partially understood. Clinically, in its classical variant, IVLBCL presents with many nonspecific signs and symptoms such as fever of unknown origin and involvement of the central nervous system and skin. Cases, which show disease limited to the skin, following extensive staging workup, are called cutaneous variants and show a better prognosis. In addition, a hemophagocytic variant associated with hemophagocytic syndrome and often with hepatosplenic involvement and cytopenia has been described. The classical and hemophagocytic variants are present mainly in western or Asian countries, respectively, although exceptions have been increasingly reported in both geographical areas. The cutaneous variant is mostly observed in western countries. Staging of IVLBCL is difficult and still not satisfactory. The often poor prognosis of this type of lymphoma has been substantially improved by immunochemotherapy, in particular with rituximab. Despite improved outcome, a significant proportion of patients relapse, in particular those with central nervous system manifestations. This review focuses on histopathological features, pathogenetic elements, presenting symptoms, clinical variants, disease progression, prognostic factors, therapeutic management, and the outcome of IVLBCL.This publication has 60 references indexed in Scilit:
- High frequency of neurolymphomatosis as a relapse disease of intravascular large B‐cell lymphomaCancer, 2011
- Chemokine triggered integrin activation and actin remodeling events guiding lymphocyte migration across vascular barriersExperimental Cell Research, 2011
- Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomasBrain Tumor Pathology, 2008
- In ReplyJournal of Clinical Oncology, 2008
- Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in JapanJournal of Clinical Oncology, 2008
- Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus MeetingJournal of Clinical Oncology, 2007
- Intravascular large B-cell lymphoma involving hemangiomas: an unusual presentation of a rare neoplasmLaboratory Investigation, 2005
- Detection of t(14;18) translocation in a case of intravascular large B-cell lymphoma: a germinal centre cell origin in a subset of these lymphomas?Histopathology, 2005
- Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1British Journal of Haematology, 2004
- Further Evidence That Malignant Angioendotheliomatosis Is an Angiotropic Large-Cell LymphomaThe New England Journal of Medicine, 1986